A review on treatment of high-risk neuroblastoma.
- Author:
Suo-Qin TANG
1
Author Information
1. Department of Pediatrics, Chinese People's Liberation Army General Hospital, Beijing 100853, China. suoqin@yahoo.com.
- Publication Type:Journal Article
- MeSH:
Combined Modality Therapy;
Female;
Humans;
Male;
Neoplasm Recurrence, Local;
therapy;
Neuroblastoma;
therapy
- From:
Chinese Journal of Contemporary Pediatrics
2014;16(2):103-107
- CountryChina
- Language:Chinese
-
Abstract:
So far treatment of advanced neuroblastoma is still difficult, due to its high malignancy. Currently comprehensive therapies, including high-dose multi-drug chemotherapy, surgery, stem cell transplantation, radiation, biological therapy and immune therapy as well as target therapy dominant the treatment of this disease, and we hereby introduce the latest development of treatment protocols for this disease.
